Project Grant R01NS148734
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $231,264.00 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of April 8, 2026, and ultimate completion date of March 31, 2031. This research project focuses on identifying and validating cerebroprotective drug targets in human stroke patients by collecting and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $520,025 to the University of Connecticut Health Center on July 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop next-generation RNA inhibitors for ischemic stroke therapy. The research focuses on developing peptide nucleic acid (PNA) analogs, particularly gamma (γ) PNA-based microRNA-141-3p (mir-141-3p)...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $429,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, with a completion date of July 31, 2027. The award supports research investigating post-ischemic protection of white matter (WM) following ischemic stroke, addressing...
- Federal Project Grant Summary Strokebridge Inc. received a $1,070,714 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 6, 2025, with a completion date of June 30, 2030. The research initiative, "Identifying Cortical and Brainstem Regions Contributing to Partial Hand Function Post-Stroke," aims to elucidate the...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Tufts College $426,650 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on June 1, 2025, with a completion date of May 31, 2027. This Project Grant supports the development of hybrid differentiation strategies to generate region-specific cell populations derived from human pluripotent stem cells (hPSCs), specifically focusing on...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Leland Stanford Junior University a Project Grant totaling $125,685 on August 9, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports research and development of a bioactive material intervention to address post-stroke dementia, a significant complication affecting approximately 7 million stroke...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pennsylvania a Project Grant of $644,345 on February 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct a multicenter randomized controlled trial evaluating MyStroke, a web-based, personalized video-based stroke education platform. The platform leverages electronic health records to deliver...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Boston University Medical Campus a Project Grant of $649,800 on May 7, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research will be conducted through February 28, 2031, at the institution's Roxbury, Massachusetts facility. This award funds a comprehensive investigation into the impact of social isolation, loneliness,...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $619,975 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 4, 2026, with completion targeted for March 31, 2031. This award funds research investigating the interaction of X chromosome effects and estrogen signaling in post-stroke...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant totaling $602,065.00 to the University of Maryland, Baltimore on March 5, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This award funds basic research investigating the molecular mechanisms by which sodium-glucose cotransporter 2 (SGLT2) regulates aquaporin-4 (AQP4), a water channel protein critical to brain...
Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $616,031 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, obligated on May 5, 2026, funds research through February 28, 2031, and supports fundamental and translational neuroscience research investigating the role of arterial endothelial pannexin 1 (PANX1) channels in ischemic stroke outcomes, with particular emphasis on age- and sex-based differences in stroke pathophysiology and recovery. The research project will deliver scientific findings and mechanistic data examining how PANX1 channels contribute to post-ischemic stroke complications, including vascular dementia and differential outcomes between sexes and age groups. Specifically, the study will investigate the interaction between arterial endothelial PANX1 and αvβ3 integrins in regulating cerebral blood flow and infarct volume, with preliminary evidence suggesting that PANX1 overexpression impairs stroke recovery particularly in female subjects. These research products will advance the understanding of novel therapeutic targets to improve ischemic stroke outcomes in populations currently ineligible for standard vascular occlusion removal interventions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $616.0k | 5/7/26 |